Bio-Path Holdings (BPTH) Misses Q1 EPS by 20c

Bio-Path Holdings (NASDAQ: BPTH) reported Q1 EPS of ($0.66), $0.20 worse than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Incyte (INCY) Reiterated at Neutral by Cantor Fitzgerald After Management Chat
• Jersey Mike's Subs (JMKE) PT Raised to $30 at Tigress Financial Partners